Skip to content

Clinical Evaluation for General Electric (GE) CT System

Clinical Evaluation for GE CT System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01909180
Enrollment
49
Registered
2013-07-26
Start date
2013-05-31
Completion date
2013-12-31
Last updated
2016-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CT Scanners X Ray

Brief summary

An external evaluation to obtain clinical data to create sample clinical images. The data will also be used for product and technology development, marketing materials, and inclusion in publications.

Detailed description

The image data were assessed using a Likert scale for image quality sufficient for diagnostic assessment.

Interventions

DEVICERevolution CT Scanner

These scans would be considered standard of care but, because the subjects are scanned on an uncleared device they are investigational.

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects who voluntarily signed the Informed Consent Form (ICF). * Male subjects 18 years of age or older. * Female subjects 18 years of age or older. Females between 18 and 60 years of age must be non-lactating and non-pregnant as confirmed by negative urine pregnancy test., unless they had surgery resulting in sterilization or are post-menopausal according to the medical history.

Exclusion criteria

* • Subjects previously enrolled in this Evaluation. * Subjects who are not able or not willing to give written Informed Consent. * For IV contrast-enhanced CT exams, anyone with known or suspected allergy to iodinated contrast agents or a history of multiple allergies or asthma. * For IV contrast-enhanced CT exams, per the institution's guidelines on risk stratification and prophylaxis for Contrast Induced Neuropathy, subjects will be pre-screened via medical history review by qualified medical personnel for suspected renal function impairment and high risk subjects will undergo a serum creatinine lab test. Any subject with proven renal insufficiency will be excluded. * Known pregnancy and nursing (lactating) females. * Any subject with urgent medical condition requiring acute care. * Any conditions that, in the opinion of the Investigator, would interfere with the evaluation of the results or constitute a health hazard for the subject. * Subjects who do not agree to allow GEHC personnel to be present during the scan.

Design outcomes

Primary

MeasureTime frameDescription
Image Quality24 hoursImage quality assessment on a 5 point Likert Scale: 5= Diagnostic- Excellent Image Quality 4= Diagnostic- Good Image Quality 3= Diagnostic-Acceptable Image Quality 2= Sub-Optimal Diagnostic with limited additional clinical information 1= Non-Diagnostic

Countries

United States

Participant flow

Participants by arm

ArmCount
Standard of Care Scan
This is a single arm clinical trial. Standard of care scan Investigational Scan
49
Total49

Baseline characteristics

CharacteristicStandard of Care Scan
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
1 Participants
Age, Categorical
Between 18 and 65 years
48 Participants
Region of Enrollment
United States
49 participants
Sex: Female, Male
Female
26 Participants
Sex: Female, Male
Male
23 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
1 / 49
serious
Total, serious adverse events
0 / 49

Outcome results

Primary

Image Quality

Image quality assessment on a 5 point Likert Scale: 5= Diagnostic- Excellent Image Quality 4= Diagnostic- Good Image Quality 3= Diagnostic-Acceptable Image Quality 2= Sub-Optimal Diagnostic with limited additional clinical information 1= Non-Diagnostic

Time frame: 24 hours

Population: All cases were sufficient and had acceptable, good or excellent image quality

ArmMeasureValue (MEAN)Dispersion
CardiacImage Quality4.53 units on a scaleStandard Deviation 0.68
Body/ ExtremityImage Quality4.44 units on a scaleStandard Deviation 0.67
NeuroImage Quality4.63 units on a scaleStandard Deviation 0.61

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026